Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Rifabutin on Trikafta PK
NCT04840862Phase 4Completed
- Sponsor
- University of Southern California
- Start
- May 2022
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of elexacaftor + tezacaftor + ivacaftor in cystic fibrosis (CF), sponsored by University of Southern California. Started May 2022; status: completed.
02
Drugs
elexacaftor + tezacaftor + ivacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT04840862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04840862.